Skip to main content

Advertisement

Table 1 Distribution of classical Kaposi sarcoma (cKS) cofactors among current study subjects and among all controls in the parent study, KCC-2

From: Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

  cKS cases Seropositive controls Seronegative controls All KCC-2 controls
  N (%) n % n % n %
Sex         
   Male 76 (64%) 72 (69%) 100 (65%) 848 (73%)
   Female 43 (36%) 33 (31%) 55 (35%) 306 (27%)
Smoking Status         
Never
Former
Current
58
51
10
(49%)
(43%)
(8%)
42
44
19
(40%)
(42%)
(18%)
70
64
21
(45%)
(41%)
(14%)
439
519
196
(38%)
(45%)
(17%)
Diabetes         
Yes
No
36
83
(30%)
(70%)
14
91
(13%)
(87%)
44
111
(28%)
(72%)
202
952
(18%)
(82%)
Cortisone use*†         
Yes
No
42
77
(35%)
(65%)
18
87
(17%)
(83%)
40
113
(26%)
(73%)
293
857
(25%)
(74%)
  mean range mean range mean range mean range
Age 75 49-94 73 39-91 73 38-91 71 32-92
  1. *During the last 10 years
  2. †Percentages may equal less than 100 due to missing data